New York, NY · Health Care · Form D filed Oct 7, 2026No press found
PreciseDx, Inc. raised $3.7M
PreciseDx, Inc. is a health care company based in New York, New York. In a Form D filed with the SEC on October 7, 2026, it reported raising $3,699,998 from 9 investors as part of an offering of up to $3,699,998. The first sale in the offering took place on September 23, 2026.
Current standards of care in oncology can be subjective, leading to a high percentage of tumors receiving intermediate grading. As a result, many patients are forced to anxiously await the results of…
No press found. No news article or press release about this raise turned up when we searched on October 17, 2026. Announcements sometimes come weeks after a filing, so we check again. More raises with no press found
- 3rd Form D since 2024. Earlier new notices: Jun 6, 2025 · Apr 1, 2024. All filings on EDGAR
$35.7M raised since 2020
3 Form D offerings, as reported to the SEC, the first in Apr 1, 2024. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 7, 2026 | $3.7M | $3.7M | 9 |
| Jun 6, 2025 | $11.2M | $15M | 9 |
| Apr 1, 2024 | $20.7M | $28.2M | 10 |
Placement agent: Aquilo Partners, L.P.
Lead score
42 out of 100
filed recently early raise budget to spend no press yet website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- precisedx.ai
- Amount raised
- $3,699,998
- Offering size
- $3,699,998
- Investors so far
- 9
- First sale
- September 23, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Health Care
- Headquarters
- New York, New York
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $3,699,998 | $3,699,998 | 9 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Oct 5, 2026 · Health Care funding in New York
Similar raises
Ramp Business Corp
New York, NY · filed Oct 1613th Form D since 2020Still raising
1921 Technologies Inc.
New York, NY · filed Oct 16First Form DStill raising
BP Commercial Funding Trust III, Series SPL-VI
New York, NY · filed Oct 162nd Form D since 2024
ShortTok, Inc.
New York, NY · filed Oct 16
5th Form D since 2022
Hypercell Technologies Inc.
Ithaca, NY · filed Oct 142nd Form D since 2021Still raising
Frictionworx Inc.
Brooklyn, NY · filed Oct 13First Form DStill raising
Atmos Clinic, Inc.
New York, NY · filed Oct 8
Affordable healthcare for working people. You set a monthly allowance, your team picks the care they need, and Atmos handles the paperwork and the IRS.
First Form DStill raising
CAD Therapeutics, Inc.
New York, NY · filed Oct 2CAD Therapeutics is developing Clonicaine™, an investigational Phase III-candidate program for PTSD focused on the physiological dimension of the condition. Clonicaine™ is not FDA-approved and is not…
First Form DStill raising